ZA99407B - Extended release tiagabine formulations with reduced side-effects. - Google Patents

Extended release tiagabine formulations with reduced side-effects.

Info

Publication number: ZA99407B
Authority: ZA; South Africa
Prior art keywords: effects; extended release; reduced side; formulations; release tiagabine
Prior art date: 1998-01-22

Application number

ZA9900407A

Other languages

English (en)

Inventor

Francisco J Alvarez

Russell T Slade

Kathleen M Apfelbaum

David M Brown

Linda E Gustavson

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-22

Filing date

1999-01-20

Publication date

1999-07-20

1999-01-20 Application filed by Abbott Lab filed Critical Abbott Lab

1999-07-20 Publication of ZA99407B publication Critical patent/ZA99407B/xx

Links

238000013265 extended release Methods 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
PBJUNZJWGZTSKL-MRXNPFEDSA-N tiagabine Chemical compound C1=CSC(C(=CCCN2C[C@@H](CCC2)C(O)=O)C2=C(C=CS2)C)=C1C PBJUNZJWGZTSKL-MRXNPFEDSA-N 0.000 title 1
229960001918 tiagabine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ZA9900407A 1998-01-22 1999-01-20 Extended release tiagabine formulations with reduced side-effects. ZA99407B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US7213098P	1998-01-22	1998-01-22

Publications (1)

Publication Number	Publication Date
ZA99407B true ZA99407B (en)	1999-07-20

Family

ID=22105780

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9900407A ZA99407B (en)	1998-01-22	1999-01-20	Extended release tiagabine formulations with reduced side-effects.

Country Status (23)

Country	Link
US (1)	US20070053980A1 (de)
EP (1)	EP1049470B1 (de)
JP (1)	JP2002501022A (de)
KR (1)	KR20010034313A (de)
CN (1)	CN1145484C (de)
AR (1)	AR018041A1 (de)
AT (1)	ATE350035T1 (de)
AU (1)	AU2239599A (de)
BG (1)	BG104692A (de)
CA (1)	CA2318448A1 (de)
CO (1)	CO4970814A1 (de)
DE (1)	DE69934670D1 (de)
HU (1)	HUP0101739A3 (de)
IL (1)	IL137324A0 (de)
NO (1)	NO20003677L (de)
NZ (1)	NZ505725A (de)
PL (1)	PL194595B1 (de)
SA (1)	SA99200204B1 (de)
SK (1)	SK11072000A3 (de)
TR (2)	TR200505223T2 (de)
TW (1)	TW585787B (de)
WO (1)	WO1999037302A1 (de)
ZA (1)	ZA99407B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6872734B2 (en)	2000-10-20	2005-03-29	Abbott Laboratories	Use of tiagabine for treatment of diabetic neuropathy and migraine
KR100510270B1 (ko) *	2002-11-29	2005-08-26	센츄론(주)	펠렛타이저를 이용한 서방성 제제의 제조방법
CN102908327B (zh) *	2011-08-05	2015-03-11	江苏恒瑞医药股份有限公司	伊伐布雷定或其可药用盐的缓释制剂
KR102051132B1 (ko) *	2017-03-17	2019-12-02	주식회사 종근당	미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5009897A (en) *	1988-06-24	1991-04-23	Abbott Laboratories	Pharmaceutical granules and tablets made therefrom
US5126145A (en) *	1989-04-13	1992-06-30	Upsher Smith Laboratories Inc	Controlled release tablet containing water soluble medicament
US5273758A (en) *	1991-03-18	1993-12-28	Sandoz Ltd.	Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms
WO1995005808A1 (en) *	1993-08-24	1995-03-02	Abbott Laboratories	Oil-based tableting method
US5430021A (en) *	1994-03-18	1995-07-04	Pharmavene, Inc.	Hydrophobic drug delivery systems
ZA953078B (en) *	1994-04-28	1996-01-05	Alza Corp	Effective therapy for epilepsies
CZ292256B6 (cs) *	1995-05-05	2003-08-13	Novo Nordisk A/S	Farmaceutická směs a způsob její přípravy
US5783212A (en) *	1996-02-02	1998-07-21	Temple University--of the Commonwealth System of Higher Education	Controlled release drug delivery system
ATE212550T1 (de) *	1997-08-01	2002-02-15	Elan Corp Plc	Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
US5843477A (en) *	1997-09-30	1998-12-01	Bayer Corporation	Lubricants for use in tabletting

1999
- 1999-01-20 ZA ZA9900407A patent/ZA99407B/xx unknown
- 1999-01-21 CO CO99003109A patent/CO4970814A1/es unknown
- 1999-01-22 AT AT99902409T patent/ATE350035T1/de not_active IP Right Cessation
- 1999-01-22 SK SK1107-2000A patent/SK11072000A3/sk unknown
- 1999-01-22 EP EP99902409A patent/EP1049470B1/de not_active Expired - Lifetime
- 1999-01-22 CA CA002318448A patent/CA2318448A1/en not_active Abandoned
- 1999-01-22 AU AU22395/99A patent/AU2239599A/en not_active Abandoned
- 1999-01-22 JP JP2000528284A patent/JP2002501022A/ja not_active Withdrawn
- 1999-01-22 CN CNB998040886A patent/CN1145484C/zh not_active Expired - Fee Related
- 1999-01-22 DE DE69934670T patent/DE69934670D1/de not_active Expired - Lifetime
- 1999-01-22 WO PCT/US1999/001242 patent/WO1999037302A1/en not_active Ceased
- 1999-01-22 HU HU0101739A patent/HUP0101739A3/hu unknown
- 1999-01-22 KR KR1020007008031A patent/KR20010034313A/ko not_active Ceased
- 1999-01-22 PL PL99342767A patent/PL194595B1/pl unknown
- 1999-01-22 NZ NZ505725A patent/NZ505725A/xx unknown
- 1999-01-22 TR TR2005/05223T patent/TR200505223T2/xx unknown
- 1999-01-22 AR ARP990100254A patent/AR018041A1/es unknown
- 1999-01-22 TR TR2000/02102T patent/TR200002102T2/xx unknown
- 1999-01-22 IL IL13732499A patent/IL137324A0/xx unknown
- 1999-03-16 TW TW088100990A patent/TW585787B/zh not_active IP Right Cessation
- 1999-06-01 SA SA99200204A patent/SA99200204B1/ar unknown
2000
- 2000-07-18 NO NO20003677A patent/NO20003677L/no not_active Application Discontinuation
- 2000-08-15 BG BG104692A patent/BG104692A/xx unknown
2006
- 2006-11-03 US US11/592,694 patent/US20070053980A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BG104692A (en)	2001-05-31
WO1999037302A1 (en)	1999-07-29
CO4970814A1 (es)	2000-11-07
DE69934670D1 (de)	2007-02-15
PL342767A1 (en)	2001-07-02
CN1145484C (zh)	2004-04-14
NO20003677D0 (no)	2000-07-18
KR20010034313A (ko)	2001-04-25
HUP0101739A2 (hu)	2002-03-28
EP1049470B1 (de)	2007-01-03
SK11072000A3 (sk)	2001-01-18
NZ505725A (en)	2003-01-31
TR200505223T2 (tr)	2006-04-21
ATE350035T1 (de)	2007-01-15
HUP0101739A3 (en)	2002-10-28
AR018041A1 (es)	2001-10-31
SA99200204B1 (ar)	2006-10-11
AU2239599A (en)	1999-08-09
IL137324A0 (en)	2001-07-24
NO20003677L (no)	2000-09-20
TR200002102T2 (tr)	2000-12-21
CA2318448A1 (en)	1999-07-29
JP2002501022A (ja)	2002-01-15
US20070053980A1 (en)	2007-03-08
EP1049470A1 (de)	2000-11-08
TW585787B (en)	2004-05-01
PL194595B1 (pl)	2007-06-29
CN1293571A (zh)	2001-05-02

Publication	Publication Date	Title
ZA993938B (en)	2000-12-14	Ziprasidone formulations.
MXPA02003750A (es)	2003-10-14	Derivados de purina.
ZA200110208B (en)	2002-12-12	Purine derivatives.
ZA200202849B (en)	2003-06-25	Purine derivatives.
ZA200000894B (en)	2000-08-24	4-Phenyl-pyridine derivatives.
MXPA01013362A (es)	2003-09-04	Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
ZA200201055B (en)	2003-07-30	Amino-triazolopyridine derivatives.
ZA200200477B (en)	2003-06-25	2-pyrazolin-5-ones.
ZA99254B (en)	1999-07-16	Benzosulfone derivatives.
EG24361A (en)	2009-03-04	4-pyrimiding1-n-acy1.l.phenlalanines
ZA200202537B (en)	2003-09-23	Pour-on-formulations.
GB0030757D0 (en)	2001-01-31	Equi-pressure geosteering
ZA200109595B (en)	2003-05-28	13-methyl-erythromycin derivatives.
ZA200201829B (en)	2003-08-27	New phenylpiperazines.
ZA200203762B (en)	2004-01-28	4-pyridinyl-IN-acyl-L-phenylalanines.
ZA992322B (en)	1999-09-20	Phosphodiesterase iv-inhibiting diazepinoindoles.
ZA992443B (en)	1999-10-01	Hydroxy-methyl-hexanones.
IL144850A (en)	2007-10-31	Resorcinol derivatives
ZA993123B (en)	1999-11-08	Trisresorcinyltriazines.
ZA995325B (en)	2000-02-22	Methylcyclotetradec-5-en-1-ones.
ZA200201276B (en)	2003-07-30	3-Amino-2-phenyl-propane derivatives.
IL137324A0 (en)	2001-07-24	Extended release tiagabine formulations with reduced side-effects
GB0029720D0 (en)	2001-01-17	I.S machine7544232001
MXPA01011285A (es)	2003-09-04	Derivados de tio-oxindol.
ZA200204581B (en)	2003-08-27	Nitro-sulfobenzamides.